Oncology News

In this edition, optimal antibiotics timing among inpatients with cancer; inflammation levels linked to survival in acute myeloid leukemia; dexrazoxane confers long-term cardioprotection for pediatric cancer and more.

In the latest Residency to Retirement column, David B. Mandell, JD, MBA, and Andrew Taylor discussed how to adequately get paid for the cash in your savings account.

In this episode, host Shikha Jain, MD, speaks with Isabelle Choi, MD, about the use of proton therapy in radiation oncology, improving accessibility to radiation technology and more.

Colorectal cancer screenings more than doubled for adults aged 45 to 49 years after the U.S. Preventive Services Task Force lowered the recommended age to start screening, a study by Epic Research found.

A prostate cancer polygenic risk score did not better predict the risk for aggressive disease compared with a clinical risk predictor and may not be clinically useful, according to study results published in JAMA Internal Medicine.

In this edition, outpatient HSCT feasible for older adults; ponatinib for newly diagnosed Ph+ALL; iomab-B may increase transplant access in relapsed/refractory AML and more.

Last week, the FDA issued a safety communication stating that it has identified cases of squamous cell carcinoma in scar tissue that formed around breast implants.

In the United States, more cases of colorectal cancer are being diagnosed at advanced stages and in younger populations, data show.

In this edition, nivolumab confers durable survival benefit; global economic cost of cancer estimated to exceed $25 trillion; phase 3 trials of pembrolizumab miss primary endpoints, and more.

The FDA is aware of 19 cases of squamous cell carcinoma in scar tissue that forms around breast implants, the agency announced today in a safety communication.